The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $14.85

Today's change-0.05 -0.34%
Updated November 22 4:00 PM EST. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $14.85

Today's change-0.05 -0.34%
Updated November 22 4:00 PM EST. Delayed by at least 15 minutes.

Meridian Bioscience Inc down (U.S.)$0.05

Meridian Bioscience Inc closed lower Wednesday, dropping (U.S.)$0.05 or 0.34% to (U.S.)$14.85. Over the last five days, shares have gained 1.37%, but are down 16.10% for the last year to date. Shares have underperformed the S&P 500 by 31.80% during the last year.

Key company metrics

  • Open(U.S.) $14.95
  • Previous close(U.S.) $14.90
  • High(U.S.) $15.10
  • Low(U.S.) $14.70
  • Bid / Ask(U.S.) $13.70 / (U.S.) $15.25
  • YTD % change-16.10%
  • Volume160,150
  • Average volume (10-day)186,229
  • Average volume (1-month)246,170
  • Average volume (3-month)217,181
  • 52-week range(U.S.) $10.75 to (U.S.) $18.58
  • Beta0.90
  • Trailing P/E29.33×
  • P/E 1 year forward22.45×
  • Forward PEG1.32×
  • Indicated annual dividend(U.S.) $0.50
  • Dividend yield3.37%
  • Trailing EPS(U.S.) $0.51
Updated November 22 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2017Q3/2017Q2/2017Q1/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue50505447
Total other revenue--------
Total revenue50505447
Gross profit31313429
Total cost of revenue19192117
Total operating expense41464037
Selling / general / administrative17161516
Research & development4443
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)17----
Other operating expenses, total--------
Operating income941410
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax941410
Income after tax6096
Income tax, total3453
Net income6096
Total adjustments to net income--------
Net income before extra. items6096
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6096
Inc. avail. to common incl. extra. items6096
Diluted net income6096
Dilution adjustment--------
Diluted weighted average shares43434343
Diluted EPS excluding extraordinary itemsvalue per share0.130.010.220.15
Dividends per sharevalue per share0.130.130.130.20
Diluted normalized EPSvalue per share0.150.110.220.15